Laura Cove-Smith
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac electrophysiology and arrhythmias
Papers in
-
- Lung Cancer Treatments and Mutations 5
- Lung Cancer Diagnosis and Treatment 2
- Oncology 8
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 3
- Co-authors
- Kim Linton (2 shared papers)John Radford (2 shared papers)Howard R. Mellor (2 shared papers)Jonathan Tugwood (2 shared papers)Hana Alachkar (1 shared paper)Rebecca Brooke (1 shared paper)Diego Cortinovis (4 shared papers)Peter Clements (1 shared paper)
- Journals
- Lung Cancer (6 papers)Journal of Thoracic Oncology (2 papers)Annals of Oncology (2 papers)Therapeutic Advances in Medical Oncology (1 paper)ESMO Open (1 paper)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
Laura Cove-Smith
20 papers receiving 278 citations
Peers
Comparison fields: 5 of 58
- Oncology 97
- Cardiology and Cardiovascular Medicine 71
- Pulmonary and Respiratory Medicine 64
- Pharmacology 29
- Geriatrics and Gerontology 5
Countries citing papers authored by Laura Cove-Smith
This map shows the geographic impact of Laura Cove-Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Cove-Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Cove-Smith more than expected).
Fields of papers citing papers by Laura Cove-Smith
This network shows the impact of papers produced by Laura Cove-Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Cove-Smith. The network helps show where Laura Cove-Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura Cove-Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 69 | |
| 2 | 2014 | 67 | |
| 3 | 2014 | 54 | |
| 4 | 2018 | 39 | |
| 5 | 2022 | 11 | |
| 6 | 2014 | 8 | |
| 7 | 2022 | 7 | |
| 8 | 2020 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 3 | |
| 11 | 2019 | 3 | |
| 12 | 2025 | 3 | |
| 13 | 2025 | 2 | |
| 14 | 2024 | 2 | |
| 15 | 2020 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2020 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2022 | 1 |
About Laura Cove-Smith
Laura Cove-Smith is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Epidemiology, having authored 23 papers that have together received 282 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (3 papers), Frailty in Older Adults (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Nutrition and Health in Aging (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Oncology (97 citations), Cardiology and Cardiovascular Medicine (71 citations), Pulmonary and Respiratory Medicine (64 citations), Pharmacology (29 citations) and Geriatrics and Gerontology (5 citations). Laura Cove-Smith has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Kim Linton, John Radford, Howard R. Mellor, Jonathan Tugwood, Hana Alachkar, Rebecca Brooke, Diego Cortinovis, Peter Clements, Brian R. Berridge and Matthias Schmitt. Their work appears in journals such as Lung Cancer, Journal of Thoracic Oncology, Annals of Oncology, Therapeutic Advances in Medical Oncology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.